AtriCure, Inc.

AtriCure, Inc. is a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. The company offers a range of products, including the Isolator Synergy Ablation System, the first medical device to receive FDA approval for the treatment of persistent Afib, as well as AtriClip Left Atrial Appendage Exclusion System products, which are the most widely used LAA management devices worldwide. AtriCure's mission is to heal the lives of those affected by Afib and pain after surgery.

The company is committed to delivering the highest quality and most efficient solutions to benefit its partners, including care providers, customers, and shareholders. It invests in innovation, clinical science, and education to focus on improving lives for patients worldwide. AtriCure is headquartered near Cincinnati, Ohio, and has over 1,200 employees worldwide. The company is publicly traded on the Nasdaq Stock Market under the ticker symbol ATRC.

AtriCure does not explicitly discuss job flexibility on their website. However, they do mention having offices in the US and Europe, suggesting a potential for remote work or flexible scheduling for certain roles. Further information regarding specific work arrangements would need to be discussed directly with the company.

AtriCure offers a comprehensive benefits package to its employees, aiming to provide support and stability. The benefits include a competitive salary, medical, dental, and vision insurance, life insurance, short- and long-term disability coverage, paid time off, and a 401(k) plan with a company match. Additionally, employees have access to a variety of wellness programs and resources. AtriCure prioritizes the well-being of its workforce by providing a robust benefits package.

AtriCure is a medical device company dedicated to improving the lives of those affected by atrial fibrillation (Afib) and post-operative pain. They are driven by a mission to reduce the global burden of Afib through innovative surgical treatments and therapies for Afib, left atrial appendage (LAA) management, and post-operative pain management. AtriCure invests in innovation, clinical science, and education to ensure the safest and most effective treatment options for patients worldwide.

AtriCure promotes a culture centered around patient care, employee empowerment, and collaboration. They prioritize patient well-being by investing in rigorous clinical science and education to ensure safe and effective treatments. Employees are encouraged to act with integrity and transparency, fostering a collaborative environment where everyone can achieve excellence and feel a sense of gratitude for their contributions. The company values its partners, including healthcare providers, customers, and shareholders, striving to understand their needs and deliver high-quality solutions that meet those needs.

AtriCure is committed to fostering a diverse, equitable, and inclusive workplace where all employees feel valued, respected, and empowered. They believe that a diverse workforce leads to innovation, creativity, and better decision-making. Their approach to diversity, equity, and inclusion (DE&I) is rooted in their core values of treating patients with respect, empowering their people, and collaborating with partners to reduce the burden of atrial fibrillation and pain after surgery.